Webinars and Sponsored Roundtables — Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice

Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Marketplace

FISH probes for glial tumors, 6/16

June 2016—Oxford Gene Technology launched its CE-IVD labeled Cytocell Aquarius 1p36/1q25 and 19q13/19p13 Deletion Probe Kit, a fluorescence in situ hybridization kit for the reliable investigation of glial tumors.

NGS assays for hematological malignancy profiling, 6/16

June 2016—ArcherDX announced three targeted next-generation sequencing assays to capture and identify known and novel gene fusions, point mutations, and relative expression levels in myeloid and lymphoid origin malignancies. The Archer FusionPlex Blood Cancer panels use Archer’s proprietary Anchored Multiplex PCR to detect known and novel fusions from RNA.

Binding Site, Rockland enter distribution agreement, 6/16

June 2016—The Binding Site Group has entered into an exclusive, definitive agreement with Rockland Immunochemicals to grant Rockland global distribution rights for Binding Site’s line of animal-focused radial immunodiffusion test kits. The RID immunoassay kits incorporate monospecific antibodies in an agarose gel to provide accurate quantitation.

Agena and Horizon partner, 6/16

June 2016—Agena Bioscience and Horizon Discovery Group announced a supply and distribution agreement to launch iPlex reference standards for performance verification of oncology assays used on the MassArray System.

Malaria detection device, 6/16

June 2016—Becton Dickinson will collaborate with Sight Diagnostics to introduce the SightDX Parasight Malaria Detection Platform in India. BD will market the platform, the company’s first malaria diagnostics offering, in the Indian diagnostics market.

Cepheid, Medline distribution agreement, 6/16

June 2016—Cepheid announced an agreement with Medline for the distribution of the Gene­Xpert System and menu of Xpert tests, which includes health care associated infections, critical infectious disease, and sexual health.

Master mix for RNA virus detection, 6/16

June 2016—Thermo Fisher Scientific launched Applied Biosystems TaqPath 1-Step Multiplex PCR Master Mix, a preformulated, universal, 4× concentration master mix designed to deliver sensitive and reproducible detection of up to four RNA (or DNA) targets in a single multiplex reaction.

Cyrex receives Canadian medical device license, 6/16

June 2016—Phoenix-based Cyrex Laboratories, a clinical immunology laboratory specializing in functional immunology and autoimmunity, was awarded a Medical Device Establishment License by Health Canada and can now service the Canadian market through licensed health care professionals.